MS Performance Tracker Showing Data From Friday June 14th After The Market Closed Two weeks into June the markets are continuing to recover from the painful volatility we experienced in April and … [Read more...] about Biopharma Stock Watch June 17th-21st
day trading
My #1 Mid-Cap Biotech Stock Pick For 2019
The four qualities that I assign the most weight when evaluating a biotech company for viability is 1) An efficacious product 2) Sufficient funding 3) Competent leadership and 4) Relationships with … [Read more...] about My #1 Mid-Cap Biotech Stock Pick For 2019
Why I am Bullish On This Phase 2b Data
Background Achieve Life Sciences (Nasdaq: ACHV) is a specialty pharmaceutical company developing a plant-based alkaloid "Cytisinicline (AKA cytisine)" as a smoking cessation drug. What is … [Read more...] about Why I am Bullish On This Phase 2b Data
Portfolio Update: ADMA Biologics
The past two months have been eventful for my number one stock pick ADMA Biologics (Nasdaq: ADMA). Moreover, on Friday May 24th, 2019 I added a new stock to the MS portfolio- Regenxbio (Nasdaq: RGNX). … [Read more...] about Portfolio Update: ADMA Biologics
Could This Biotech Stock Get Bought For $5.5 Billion? Either Way I’m Buying It
On Friday May 24th, 2019 Novartis (NYSE: NVS) gained FDA approval of its gene therapy product " Zolgensma® " for spinal muscular atrophy (SMA), originally purchased from AveXis in 2018 for $8.7 … [Read more...] about Could This Biotech Stock Get Bought For $5.5 Billion? Either Way I’m Buying It
A High-Risk, High-Reward Biotech Stock Targeting NASH Cirrhosis
In this next article in our series on investing in NASH I want to jump to the other end of the spectrum. In "Investing In This Biotech Sector Could Triple Your Net Wealth In 3-Years" I painted a … [Read more...] about A High-Risk, High-Reward Biotech Stock Targeting NASH Cirrhosis
An Attractive Biotech Stock Gunning For NASH
In my previous article "Investing In This Biotech Sector Could Triple Your Net Wealth In 3-Years" I laid out my rationale for investing in NAFLD/NASH companies. I reasoned that by investing in … [Read more...] about An Attractive Biotech Stock Gunning For NASH
Investor Alert: Endra Life Scienes (NDRA)
Background Endra Life Sciences (NDRA) is a clinical stage medical device company we started following in April, 2019. The share price galloped up to a high near $3.30 in March in anticipation of … [Read more...] about Investor Alert: Endra Life Scienes (NDRA)
Biopharma Stock Watch May 20th-24th
The past week of trading was a mixed bag. On Monday we saw what I would call a "flash crash". The DJI dropped over 600 points in the morning (-2.4%) and proceeded to have its worst day this year since … [Read more...] about Biopharma Stock Watch May 20th-24th
ADMA HALTED Pending News
A heads up to any of our team members who may be in ADMA Biologics (Nasdaq: ADMA). Today, after the market closed the ADMA's stock, was halted pending news. I assume the news is regarding the approval … [Read more...] about ADMA HALTED Pending News
You must be logged in to post a comment.